Delivery of TPST-2003 lentiviral vector to Cincinnati Children’s Applied Gene and Cell Therapy Center enables manufacturing activities required ...

The global lentiviral vector CDMO market is projected to grow at a CAGR of 8% over the next five years. This growth is driven by rising demand for gene and cell therapies, an expanding pipeline of ...

Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.

Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved ...

A 2026 informational overview of the ODIN Faraday Bag's EMF signal-blocking shielding design, Faraday cage attenuation ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric antigen receptor T cell) therapies that modify a patient’s T cells, which play ...

Research reveals that AI contains emotion vectors. You can invoke those vectors. You can avoid them. This is about emotional manipulations. An AI Insider scoop.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...

In the cloud, AI runs in a kind of computational luxury. Thousands of GPUs and CPUs sit in climate-controlled buildings with access to ample power and memory. Utilization may be inefficient—often just ...